Eyebright Medical(SH:688050) Xin Lang Cai Jing·2025-09-23 06:06Group 1 - Aibo Medical's stock price dropped by 5.02% to 72.28 CNY per share, with a trading volume of 239 million CNY and a turnover rate of 1.71%, resulting in a total market capitalization of 13.979 billion CNY [1] - Aibo Medical, established on April 21, 2010, and listed on July 29, 2020, specializes in the research, production, sales, and related services of ophthalmic medical devices [1] - The company's main revenue sources include intraocular lenses (43.86%), contact lenses (30.06%), orthokeratology lenses (15.14%), myopia control products (6.01%), other surgical products (2.37%), vision care products (1.62%), and other income (0.95%) [1] Group 2 - Huabao Fund's Huabao CSI Medical ETF (512170) is among the top ten circulating shareholders of Aibo Medical, having increased its holdings by 231,800 shares in Q2, totaling 4.4169 million shares, which represents 2.33% of the circulating shares [2] - The estimated floating loss for Huabao CSI Medical ETF today is approximately 16.8725 million CNY [2] - The fund was established on May 20, 2019, with a current size of 26.147 billion CNY, yielding 18.43% year-to-date and 42.82% over the past year, ranking 2736 out of 4220 and 2434 out of 3814 in its category, respectively [2]